Sanofi-Aventis Inks $500M Deal For Cancer Therapy
Sanofi-Aventis has signed a deal with a Massachusetts biopharmaceutical company granting the French pharmaceutical giant the exclusive worldwide license to an antibody that may potentially be used in treating cancer....To view the full article, register now.
Already a subscriber? Click here to view full article